The Pancreatic Beta Cell Consortium’s efforts will have positive consequences for the more than 100 million people around the world who are living with diabetes.
This chronic disease, which occurs when the pancreas does not produce insulin, can lead to blindness, heart attack, kidney failure, stroke, lower limb amputation, and/or death. We are united around resolving the problem of diabetes with our focus on the pancreatic beta cell, the cell whose primary function is to store and release insulin.
The Pancreatic Beta Cell Consortium are a team of artists, engineers, scientists and physicians who are bringing together an array of scientific data types and experimental methods for the construction of a dynamic, three-dimensional model of the pancreatic beta cell. Our models represent a sophisticated convergence of cellular structure and function, and we believe this work will revolutionize biological discovery and accelerate advancements in diabetes treatments and therapies.
To learn more about the Pancreatic Beta Cell Consortium, click here for their website.
Our Lab Partners
Our lab partners in the Pancreatic Beta Cell Consortium are some of the top experimentalists in their respective fields. There are over 13 labs at USC involved and a total over 30 groups worldwide from academia and industry.